The current study increases the limited evidence of the relationship between BMP9 and NAFLD as well as MetS, suggesting serum BMP9 was a new biomarker for noninvasive stratification of NAFLD and MetS. This evidence concerns the gene GDF2 and metabolic dysfunction-associated steatotic liver disease.